Selected research
Industry Research
Piroxicam Capsules Industry Research Report 2026
Market perspective
The global Piroxicam Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Piroxicam Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Piroxicam Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Piroxicam Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Piroxicam Capsules include Chongqing Kerui Pharmaceutical, Pfizer, Guangzhou Ouhua Pharmaceutica, Baiyunshan, Guangdong Zhongsheng Pharmaceutical, Guangdong Xinfeng Pharmaceutical, Guangdong Pidi Pharmaceutical, Teva Pharmaceuticals USA and SK Chemical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Piroxicam Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Piroxicam Capsules Market by Company
Chongqing Kerui Pharmaceutical
Pfizer
Guangzhou Ouhua Pharmaceutica
Baiyunshan
Guangdong Zhongsheng Pharmaceutical
Guangdong Xinfeng Pharmaceutical
Guangdong Pidi Pharmaceutical
Teva Pharmaceuticals USA
SK Chemical
Nouvasant Group
Elikem Pharmaceuticals
DevLife
AdvaCare Pharma
Piroxicam Capsules Segment by Type
Regular Release
Modified Release
Piroxicam Capsules Segment by Application
Hospital
Clinic
Pharmacy
Piroxicam Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Piroxicam Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Piroxicam Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Piroxicam Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Piroxicam Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Regular Release
- Modified Release
Applications
- Hospital
- Clinic
- Pharmacy
Companies covered
- Chongqing Kerui Pharmaceutical
- Pfizer
- Guangzhou Ouhua Pharmaceutica
- Baiyunshan
- Guangdong Zhongsheng Pharmaceutical
- Guangdong Xinfeng Pharmaceutical
- Guangdong Pidi Pharmaceutical
- Teva Pharmaceuticals USA
- SK Chemical
- Nouvasant Group
- Elikem Pharmaceuticals
- DevLife
- AdvaCare Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Piroxicam Capsules Market Size (2021-2032)
- 2.2.2 Global Piroxicam Capsules Sales (2021-2032)
- 2.2.3 Global Piroxicam Capsules Market Average Price (2021-2032)
- 2.3 Piroxicam Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Regular Release
- 2.3.3 Modified Release
- 2.4 Piroxicam Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Piroxicam Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Piroxicam Capsules Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Piroxicam Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Piroxicam Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Piroxicam Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Piroxicam Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Piroxicam Capsules, Product Type & Application
- 3.8 Global Manufacturers of Piroxicam Capsules, Established Date
- 3.9 Global Piroxicam Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chongqing Kerui Pharmaceutical
- 4.1.1 Chongqing Kerui Pharmaceutical Company Information
- 4.1.2 Chongqing Kerui Pharmaceutical Business Overview
- 4.1.3 Chongqing Kerui Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chongqing Kerui Pharmaceutical Piroxicam Capsules Product Portfolio
- 4.1.5 Chongqing Kerui Pharmaceutical Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Piroxicam Capsules Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 Guangzhou Ouhua Pharmaceutica
- 4.3.1 Guangzhou Ouhua Pharmaceutica Company Information
- 4.3.2 Guangzhou Ouhua Pharmaceutica Business Overview
- 4.3.3 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Guangzhou Ouhua Pharmaceutica Piroxicam Capsules Product Portfolio
- 4.3.5 Guangzhou Ouhua Pharmaceutica Recent Developments
- 4.4 Baiyunshan
- 4.4.1 Baiyunshan Company Information
- 4.4.2 Baiyunshan Business Overview
- 4.4.3 Baiyunshan Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Baiyunshan Piroxicam Capsules Product Portfolio
- 4.4.5 Baiyunshan Recent Developments
- 4.5 Guangdong Zhongsheng Pharmaceutical
- 4.5.1 Guangdong Zhongsheng Pharmaceutical Company Information
- 4.5.2 Guangdong Zhongsheng Pharmaceutical Business Overview
- 4.5.3 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Guangdong Zhongsheng Pharmaceutical Piroxicam Capsules Product Portfolio
- 4.5.5 Guangdong Zhongsheng Pharmaceutical Recent Developments
- 4.6 Guangdong Xinfeng Pharmaceutical
- 4.6.1 Guangdong Xinfeng Pharmaceutical Company Information
- 4.6.2 Guangdong Xinfeng Pharmaceutical Business Overview
- 4.6.3 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Guangdong Xinfeng Pharmaceutical Piroxicam Capsules Product Portfolio
- 4.6.5 Guangdong Xinfeng Pharmaceutical Recent Developments
- 4.7 Guangdong Pidi Pharmaceutical
- 4.7.1 Guangdong Pidi Pharmaceutical Company Information
- 4.7.2 Guangdong Pidi Pharmaceutical Business Overview
- 4.7.3 Guangdong Pidi Pharmaceutical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Guangdong Pidi Pharmaceutical Piroxicam Capsules Product Portfolio
- 4.7.5 Guangdong Pidi Pharmaceutical Recent Developments
- 4.8 Teva Pharmaceuticals USA
- 4.8.1 Teva Pharmaceuticals USA Company Information
- 4.8.2 Teva Pharmaceuticals USA Business Overview
- 4.8.3 Teva Pharmaceuticals USA Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Teva Pharmaceuticals USA Piroxicam Capsules Product Portfolio
- 4.8.5 Teva Pharmaceuticals USA Recent Developments
- 4.9 SK Chemical
- 4.9.1 SK Chemical Company Information
- 4.9.2 SK Chemical Business Overview
- 4.9.3 SK Chemical Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SK Chemical Piroxicam Capsules Product Portfolio
- 4.9.5 SK Chemical Recent Developments
- 4.10 Nouvasant Group
- 4.10.1 Nouvasant Group Company Information
- 4.10.2 Nouvasant Group Business Overview
- 4.10.3 Nouvasant Group Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Nouvasant Group Piroxicam Capsules Product Portfolio
- 4.10.5 Nouvasant Group Recent Developments
- 4.11 Elikem Pharmaceuticals
- 4.11.1 Elikem Pharmaceuticals Company Information
- 4.11.2 Elikem Pharmaceuticals Business Overview
- 4.11.3 Elikem Pharmaceuticals Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Elikem Pharmaceuticals Piroxicam Capsules Product Portfolio
- 4.11.5 Elikem Pharmaceuticals Recent Developments
- 4.12 DevLife
- 4.12.1 DevLife Company Information
- 4.12.2 DevLife Business Overview
- 4.12.3 DevLife Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 DevLife Piroxicam Capsules Product Portfolio
- 4.12.5 DevLife Recent Developments
- 4.13 AdvaCare Pharma
- 4.13.1 AdvaCare Pharma Company Information
- 4.13.2 AdvaCare Pharma Business Overview
- 4.13.3 AdvaCare Pharma Piroxicam Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 AdvaCare Pharma Piroxicam Capsules Product Portfolio
- 4.13.5 AdvaCare Pharma Recent Developments
5 Global Piroxicam Capsules Market Scenario by Region
- 5.1 Global Piroxicam Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Piroxicam Capsules Sales by Region: 2021-2032
- 5.2.1 Global Piroxicam Capsules Sales by Region: 2021-2026
- 5.2.2 Global Piroxicam Capsules Sales by Region: 2027-2032
- 5.3 Global Piroxicam Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Piroxicam Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Piroxicam Capsules Revenue by Region: 2027-2032
- 5.4 North America Piroxicam Capsules Market Facts & Figures by Country
- 5.4.1 North America Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Piroxicam Capsules Sales by Country (2021-2032)
- 5.4.3 North America Piroxicam Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Piroxicam Capsules Market Facts & Figures by Country
- 5.5.1 Europe Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Piroxicam Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Piroxicam Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Piroxicam Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Piroxicam Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Piroxicam Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Piroxicam Capsules Market Facts & Figures by Country
- 5.7.1 South America Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Piroxicam Capsules Sales by Country (2021-2032)
- 5.7.3 South America Piroxicam Capsules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Piroxicam Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Piroxicam Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Piroxicam Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Piroxicam Capsules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Piroxicam Capsules Sales by Type (2021-2032)
- 6.1.1 Global Piroxicam Capsules Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Piroxicam Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Piroxicam Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Piroxicam Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Piroxicam Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Piroxicam Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Piroxicam Capsules Sales by Application (2021-2032)
- 7.1.1 Global Piroxicam Capsules Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Piroxicam Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Piroxicam Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Piroxicam Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Piroxicam Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Piroxicam Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Piroxicam Capsules Value Chain Analysis
- 8.1.1 Piroxicam Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Piroxicam Capsules Production Mode & Process
- 8.2 Piroxicam Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Piroxicam Capsules Distributors
- 8.2.3 Piroxicam Capsules Customers
9 Global Piroxicam Capsules Analyzing Market Dynamics
- 9.1 Piroxicam Capsules Industry Trends
- 9.2 Piroxicam Capsules Industry Drivers
- 9.3 Piroxicam Capsules Industry Opportunities and Challenges
- 9.4 Piroxicam Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst